Metformin – mechanisms of action and use for the treatment of type 2 diabetes mellitus

Apply

Metformin – mechanisms of action and use for the treatment of type 2 diabetes mellitus

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0

Abstract

Metformin is widely used for the treatment of type 2 diabetes mellitus. Although this biguanide derivative has been used for more than 50 years, its mechanism of action has not been fully elucidated. In this article we describe the latest achievements concerning the mechanisms of antihyperglycemic action of metformin. They include: decrease of glucose absorption in the small intestine, increase of glucose transport into cells, decrease in the plasma free fatty acid concentrations and inhibition of gluconeogenesis. Activation of AMP-activated protein kinase (AMPK) plays an important role in these processes. The latest discoveries have revealed mechanisms of anti-atherosclerotic, hypotensive and anticancer action of metformin and its impact on vein endothelial function. The pleiotropic actions of metformin include impact on plasma lipid profile, decrease of oxidative stress, and increase in plasma fibrinolytic activity. Although metformin is not metabolized, the latest research has shown that it is actively transported into hepatocytes and renal tubular epithelium, by OCT1 (organic cation transporter 1, encoded by the [i]SLC22A1[/i] gene) and OCT2 (organic cation transporter 2, encoded by the [i]SLC22A2[/i] gene), respectively. However, MATE1 transporter (multidrug and toxin extrusion 1 protein) is encoded by the [i]SLC47A1[/i] gene and facilitates metformin excretion from these cells into bile and urine. Metformin transporter gene polymorphisms may contribute to significant variation in drug response. Further studies of mechanisms of metformin action could contribute to its wider use for the prevention of type 2 diabetes mellitus, cancer, and Alzheimer’s disease, and for the treatment of type 1 diabetes mellitus, and polycystic ovary syndrome (PCOS).

Authors and Affiliations

Marzena Grzybowska, Joanna Bober, Maria Olszewska

Keywords

Breast cancer metastasis – insight into selected molecular mechanisms of the phenomenon

Metastasis is a complex, multistep biological process, involving a multitude of genes and biomolecules. Despite the successful therapeutic management of breast cancer, including surgery, chemotherapy and radiation therap...

Fosfodiesterazy rodziny 3 sprzęgają szlaki sygnałowe zależne od kinaz białkowych i cyklicznego GMP z metabolizmem cyklicznego AMP

PDE3 są fosfodiesterazami dwusubstratowymi, hydrolizującymi cAMP i cGMP. Jednocześnie ich aktywność katalityczna jest hamowana kompetycyjnie przez cGMP. Jest to związane z obecnością 44-aminokwasowego insertu w domenie...

EP ID EP66474
DOI -
Views 167
Downloads 0